A recent study sought to determine if clinical benefits of novel anticancer drugs have increased over time in conjunction with increasing costs.
The American Society for Radiation Oncology has provided an update to its clinical guideline for palliative-intent radiation therapy in patients with lung cancer, recommending concurrent chemotherapy for some patients with stage III disease.
The American Diabetes Association Standards of Medical Care and Diabetes 2018 offers a range of recommendations for cardiovascular disease and risk management in nonpregnant adults with diabetes.
The American Society of Clinical Oncology has released new guidelines to address abiraterone or docetaxel with androgen-deprivation therapy for metastatic prostate cancer that has not been treated with testosterone-lowering agents.
A recent study compared the costs and toxicities of proton radiation, stereotactic body radiotherapy, and intensity-modulated radiotherapy for younger patients with prostate cancer.
The Institute for Clinical and Economic Review has announced plans to launch a new model transparency program for its drug assessment review process.
Whole-genome sequencing does not increase downstream healthcare spending outside of the sequencing costs.
The National Comprehensive Cancer Network has issued updated guidelines for average-risk and high-risk colorectal cancer screening.
Robin T Zon, MD, FACP, FASCO, and Bobby Daly, MD, MBA, discuss ASCO's recently published results of an evaluation of national pathway vendors against the Criteria for High-Quality Clinical Pathways.
The ASCO Patient-Centered Oncology Payment model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period.